More recently, we showed that ALDH1 is a marker of tumor initiating cells and drug resistance in myeloma, and that the CIN signature is more highly expressed in ALDH1+ than ALDH1− myeloma cells [14]. The gene discussed is ALDH1A1; the disease is plasma cell myeloma.